Senate Counsel, Research
and Fiscal Analysis
Minnesota Senate Bldg.
95 University Avenue W. Suite 3300
St. Paul, MN 55155
(651) 296-4791
Tom Bottern
Director
   Senate   
State of Minnesota
 
 
 
 
 
S.F. No. 1523 - Department of Commerce Health Policy Bill (First Engrossment)
 
Author: Senator Tony Lourey
 
Prepared By: Christopher B. Stang, Senate Counsel (651/296-0539)
 
Date: April 29, 2015



 

Section 1 provides that health plans that have a multi-tier benefit structure for prescription drugs are in compliance with this section regulating cancer chemotherapy treatment if the plan does not include orally administered anticancer medication in the coverage tier with the highest cost-sharing.

Sections 2 and 4 restore specified rating requirements for grandfathered plans that were deleted in legislation two years ago.

Sections 3 and 5 are technical correction changes related to dependent children and portability of coverage, respectively.

Section 6 extends the amount of time a consumer has to request external review of adverse determination by an insurer from 6 to 9 months.

 

CBS/tg

 
Check on the status of this bill
 
Back to Senate Counsel and Research Bill Summaries page
 

 
This page is maintained by the Office of Senate Counsel, Research, and Fiscal Analysis for the Minnesota Senate.
 
Last review or update: 04/29/2015
 
If you see any errors on this page, please e-mail us at webmaster@senate.mn